By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Boston Biomedica, Inc. 

375 West Street

W. Bridgewater  Massachusetts  02379  U.S.A.
Phone: 508-580-1900 Fax: 508-580-1110

Boston Biomedica, Inc. provides products and services for the detection and monitoring of infectious diseases such as AIDS and Viral Hepatitis. BBI has three operating business units:

  • BBI Diagnostics, an ISO 9001 certified manufacturer and supplier of quality control and diagnostics reagents used to increase the accuracy of in vitro diagnostic tests.
  • BBI Biotech Research Laboratories, a research and development center providing R&D support for the other BBI business units, as well as contract research and repository services for the government, industry and other third parties.
  • BBI Source Scientific, an ISO 9001 certified manufacturer of diagnostic instrumentation and medical devices.

In addition, BBI is conducting research and development in Pressure Cycling Technology (PCT) through its subsidiary BBI BioSeq, with the goal of introducing new solutions for a number of important healthcare issues, including: inactivation of pathogens in human plasma, extraction of nucleic acids, food safety, and genomics. BBI also maintains a passive investment in Panacos Pharmaceuticals, a privately held antiviral drug and vaccine development company recently spun-off from BBI, whose goal is to introduce new solutions for the treatment of infectious diseases.

Last Updated 8-28-01

Key Statistics

Ownership: Public

Web Site: Boston Biomedica, Inc.
Employees: 275
Symbol: BBII


Company News
Pressure BioSciences, Inc. (BBII) Announces Stock Repurchase Program 9/25/2006 9:57:15 AM
Pressure BioSciences, Inc. (BBII) Announces Extension Of Tender Offer10/19/2005 5:12:38 PM
Boston Biomedica (BBII) Announces Sale Of BBI Source Scientific10/19/2005 5:11:43 PM
Boston Biomedica (BBII) Reports First Quarter 2004 Financial Results10/19/2005 5:11:23 PM
Boston Biomedica (BBII) Announces The Appointment Of Richard T. Schumacher As Chief Executive Officer (CEO)10/19/2005 5:10:58 PM
Boston Biomedica (BBII) Announces Agreement To Sell its Diagnostics And Biotech Divisions To SeraCare Life Sciences, Inc. (SRLS) 10/19/2005 5:10:56 PM
Boston Biomedica (BBII) Reports Third Quarter Operating Results10/19/2005 5:10:47 PM
Boston Biomedica (BBII) Reports Fourth Quarter And Fiscal Year End 2003 Financial Results10/19/2005 5:10:40 PM
Michael N. Avallone Promoted To Chief Financial Officer Of Boston Biomedica (BBII)10/19/2005 5:10:31 PM
Boston Biomedica (BBII) Announces Completion Of A $2.5 Million Revolving Credit And Security Agreement10/19/2005 5:09:59 PM